Active Ingredient: LUMASIRAN SODIUM
Proprietary Name: OXLUMO
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214103
Product Number: 001
Approval Date: Nov 23, 2020
Applicant Holder Full Name: ALNYLAM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
